(Q57226040)

English

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea

scholarly article by Boksoon Chang et al published December 2011 in Clinical Rheumatology

In more languages

Statements

scholarly article

0 references

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

latent tuberculosis

1 reference

based on heuristic

inferred from title

8

object named as

Won-Jung Koh

0 references

3

object named as

Kyeongman Jeon

0 references

author name string

Boksoon Chang

1

0 references

Hye Yun Park

2

0 references

Joong Kyong Ahn

4

0 references

Hoon-Suk Cha

5

0 references

Eun-Mi Koh

6

0 references

Eun-Suk Kang

7

0 references

language of work or name

0 references

publication date

December 2011

0 references

Clinical Rheumatology

0 references

30

0 references

12

0 references

1535-41

0 references

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1771-9

21 January 2018

Guidelines for conducting tuberculin skin test surveys in high-prevalence countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor-alpha and tuberculosis: guidance from the National TB Advisory Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A COMPARISON IN THE UNITED STATES OF AMERICA OF TWO TUBERCULINS, PPD-S AND RT 23

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for conducting tuberculin skin test surveys in high-prevalence countries [Second edition].

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-011-1771-9

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57226040&oldid=1674045560"